Our Mission

St. Anna Children’s Cancer Research Institute (St. Anna CCRI) strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. Every year, 300-350 children and adolescents in Austria alone are diagnosed with cancer. Thanks to research, more than 80 % of these children will now survive. Integrally connected with St. Anna Children’s Hospital, experimental and theoretical scientists at St. Anna CCRI work side-by-side with oncologists to tackle eminent issues in pediatric cancer research and therapy.

St. Anna CCRI trains a generation of passionate and courageous researchers thriving on this interdisciplinary exchange and it hosts state-of-the-art experimental facilities to power this mission. The institute tears down conventional boundaries by constant exchange and collaboration with outside institutions in order to go the extra mile for the benefit of the patient. Bringing research from bench to bedside, St. Anna CCRI headquarters multiple clinical trials and is tightly integrated in international networks to maximize innovation and impact.

New Scientific Directors: Eleni Tomazou and Sabine Taschner-Mandl

Science Report 2024

The year saw remarkable milestones in scientific excellence, including the official launch of the MONALISA project aimed at improving surveillance and treatment for high-risk neuroblastoma. We also celebrated the start of a three-year project focused on new therapies for Ewing sarcoma and the initiation of the DART2OS project, which explores new T-cell therapies for osteosarcoma.

Discover these and many more milestones in our latest Science Report.

Social Media

Upcoming event: